For some couples, the journey to parenthood includes a desire to balance their family or select a specific gender. While many people pursue IVF due to fertility challenges, others explore it for this very reason.
During In Vitro Fertilization (IVF), there is an advanced option known as Preimplantation Genetic Testing for Aneuploidy (PGT-A). This process allows specialists to assess embryos before they are transferred to the uterus.
After eggs are fertilized in the laboratory and embryos are formed, a few cells are carefully taken from each embryo in a highly controlled and safe procedure. These cells are then analyzed by a specialized genetics team. The purpose of this testing is to examine the chromosomes within each embryo.
Through this screening, embryos can be identified as having:
- XX chromosomes (female)
- XY chromosomes (male)
In addition to identifying gender, PGT-A also helps determine which embryos have the correct number of chromosomes, supporting healthier pregnancy outcomes.
Once the results are available, your fertility specialist will guide you in selecting an embryo for transfer based on your preferences and medical considerations. If pregnancy occurs, the baby’s gender will correspond to the selected embryo.
PGT-A is currently the most reliable method available for gender selection during IVF, offering a very high level of accuracy.
It’s important to note that not all fertility clinics offer this service, and regulations or ethical guidelines may vary. If gender selection is something you are considering, we encourage you to discuss this option with your fertility specialist to understand what is available and appropriate for your situation.
Our priority is to support you with compassionate care, clear information, and the most advanced reproductive technologies—so you can make confident decisions about your family’s future.